| Ident. | Authors (with country if any) | Title |
|---|
| 001782 (2014) |
Chung-Ke Chang [Taïwan] ; Ming-Hon Hou [Taïwan] ; Chi-Fon Chang [Taïwan] ; Chwan-Deng Hsiao [Taïwan] ; Tai-Huang Huang [Taïwan] | The SARS coronavirus nucleocapsid protein - Forms and functions |
| 001786 (2014) |
Christopher M. Coleman [États-Unis] ; Ye V. Liu [États-Unis] ; HAIYAN MU [États-Unis] ; Justin K. Taylor [États-Unis] ; Michael Massare [États-Unis] ; David C. Flyer [États-Unis] ; Gregory M. Glenn [États-Unis] ; Gale E. Smith [États-Unis] ; Matthew B. Frieman [États-Unis] | Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice |
| 001788 (2014) |
Adeyemi O. Adedeji [États-Unis] ; Kamalendra Singh [États-Unis] ; Ademola Kassim [États-Unis] ; Christopher M. Coleman [États-Unis] ; Ruth Elliott [États-Unis] ; Susan R. Weiss [États-Unis] ; Matthew B. Frieman [États-Unis] ; Stefan G. Sarafianos [États-Unis] | Evaluation of SSYA10-001 as a Replication Inhibitor of Severe Acute Respiratory Syndrome, Mouse Hepatitis, and Middle East Respiratory Syndrome Coronaviruses |
| 001789 (2014) |
S. M. Goyal [États-Unis] ; Y. Chander [États-Unis] ; S. Yezli [Royaume-Uni] ; J. A. Otter [Royaume-Uni] | Evaluating the virucidal efficacy of hydrogen peroxide vapour |
| 001A38 (2013) |
Christopher Chang [États-Unis] | Unmet Needs in Respiratory Diseases |
| 001C04 (2013) |
FANG LI [États-Unis] | Receptor recognition and cross-species infections of SARS coronavirus |
| 001C05 (2013) |
Graham Simmons [États-Unis] ; Pawel Zmora [Allemagne] ; Stefanie Gierer [Allemagne] ; Adeline Heurich [Allemagne] ; Stefan Pöhlmann [Allemagne] | Proteolytic activation of the SARS-coronavirus spike protein: Cutting enzymes at the cutting edge of antiviral research |
| 001C08 (2013) |
Rolf Hilgenfeld [Allemagne] ; Malik Peiris [Hong Kong] | From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses |
| 001C09 (2013) |
Kwok-Hung Chan [Hong Kong] ; Jasper Fuk-Woo Chan [Hong Kong] ; Herman Tse [Hong Kong] ; HONGLIN CHEN [Hong Kong] ; Candy Choi-Yi Lau [Hong Kong] ; Jian-Piao Cai [Hong Kong] ; Alan Ka-Lun Tsang [Hong Kong] ; XINCAI XIAO [République populaire de Chine] ; Kelvin Kai-Wang To [Hong Kong] ; Susanna Kar-Pui Lau [Hong Kong] ; Patrick Chiu-Yat Woo [Hong Kong] ; Bo-Jiang Zheng [Hong Kong] ; MING WANG [République populaire de Chine] ; Kwok-Yung Yuen [Hong Kong] | Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests |
| 001C10 (2013) |
Vincent C. C. Cheng [Hong Kong] ; Jasper F. W. Chan [Hong Kong] ; Kelvin K. W. To [Hong Kong] ; K. Y. Yuen [Hong Kong] | Clinical management and infection control of SARS: Lessons learned |
| 001E84 (2012) |
Shumpei Tsuda [Japon] ; Shumpei Watanabe [Japon] ; Joseph S. Masangkay [Philippines] ; Tetsuya Mizutani [Japon] ; Phillip Alviola [Philippines] ; Naoya Ueda [Japon] ; Koichiro Iha [Japon] ; Satoshi Taniguchi [Japon] ; Hikaru Fujii [Japon] ; Kentaro Kato [Japon] ; Taisuke Horimoto [Japon] ; Shigeru Kyuwa [Japon] ; Yasuhiro Yoshikawa [Japon] ; Hiroomi Akashi [Japon] | Genomic and serological detection of bat coronavirus from bats in the Philippines |
| 001F08 (2012) |
Shih-Wen Li [Taïwan] ; Tsuey-Ching Yang [Taïwan] ; Lei Wan [Taïwan] ; Ying-Ju Lin [Taïwan] ; Fuu-Jen Tsai [Taïwan] ; Chien-Chen Lai [Taïwan] ; Cheng-Wen Lin [Taïwan] | Correlation between TGF‐β1 expression and proteomic profiling induced by severe acute respiratory syndrome coronavirus papain‐like protease |
| 001F62 (2012) |
Miyuki Kawase [Japon] ; Kazuya Shirato [Japon] ; Lia Van Der Hoek [Pays-Bas] ; Fumihiro Taguchi [Japon] ; Shutoku Matsuyama [Japon] | Simultaneous Treatment of Human Bronchial Epithelial Cells with Serine and Cysteine Protease Inhibitors Prevents Severe Acute Respiratory Syndrome Coronavirus Entry |
| 001F63 (2012) |
Tomohisa Tanaka [Japon] ; Wataru Kamitani [Japon] ; Marta L. Dediego [Espagne] ; Luis Enjuanes [Espagne] ; Yoshiharu Matsuura [Japon] | Severe Acute Respiratory Syndrome Coronavirus nsp1 Facilitates Efficient Propagation in Cells through a Specific Translational Shutoff of Host mRNA |
| 001F64 (2012) |
Martha Schneider [Allemagne] ; Kerstin Ackermann [Allemagne] ; Melissa Stuart [États-Unis] ; Claudia Wex [Allemagne] ; Ulrike Protzer [Allemagne] ; Hermann M. Sch Tzl [Allemagne, États-Unis] ; Sabine Gilch [Allemagne, États-Unis] | Severe Acute Respiratory Syndrome Coronavirus Replication Is Severely Impaired by MG132 due to Proteasome-Independent Inhibition of M-Calpain |
| 001F65 (2012) |
Adeyemi O. Adedeji [États-Unis] ; Kamalendra Singh [États-Unis] ; Nicholas E. Calcaterra [États-Unis] ; Marta L. Dediego [Espagne] ; Luis Enjuanes [Espagne] ; Susan Weiss [États-Unis] ; Stefan G. Sarafianos [États-Unis] | Severe Acute Respiratory Syndrome Coronavirus Replication Inhibitor That Interferes with the Nucleic Acid Unwinding of the Viral Helicase |
| 001F66 (2012) |
Kumari G. Lokugamage [États-Unis] ; Krishna Narayanan [États-Unis] ; CHENG HUANG [États-Unis] ; Shinji Makino [États-Unis] | Severe Acute Respiratory Syndrome Coronavirus Protein nsp1 Is a Novel Eukaryotic Translation Inhibitor That Represses Multiple Steps of Translation Initiation |
| 001F69 (2012) |
BING HAN [Canada] ; XUEZHONG MA [Canada] ; JIANHUA ZHANG [Canada] ; YU ZHANG [Canada] ; XIAOHUI BAI [Canada] ; David M. Hwang [Canada] ; Shaf Keshavjee [Canada] ; Gary A. Levy [Canada] ; Ian Mcgilvray [Canada] ; MINGYAO LIU [Canada] | Protective effects of long pentraxin PTX3 on lung injury in a severe acute respiratory syndrome model in mice |
| 001F70 (2012) |
Candice Clay [États-Unis] ; Nathan Donart [États-Unis] ; Ndingsa Fomukong [États-Unis] ; Jennifer B. Knight [États-Unis] ; WANLI LEI [États-Unis] ; Lance Price [États-Unis] ; Fletcher Hahn [États-Unis] ; Jesse Van Westrienen [États-Unis] ; Kevin S. Harrod [États-Unis] | Primary Severe Acute Respiratory Syndrome Coronavirus Infection Limits Replication but Not Lung Inflammation upon Homologous Rechallenge |
| 001F73 (2012) |
Masaya Fukushi [Japon] ; Yoshiyuki Yoshinaka [Japon] ; Yusuke Matsuoka [Japon] ; Seisuke Hatakeyama [Japon] ; Yukihito Ishizaka [Japon] ; Teruo Kirikae [Japon] ; Takehiko Sasazuki [Japon] ; Tohru Miyoshi-Akiyama [Japon] | Monitoring of S Protein Maturation in the Endoplasmic Reticulum by Calnexin Is Important for the Infectivity of Severe Acute Respiratory Syndrome Coronavirus |
| 001F74 (2012) |
Matthew Frieman [États-Unis] ; Boyd Yount [États-Unis] ; Sudhakar Agnihothram [États-Unis] ; Carly Page [États-Unis] ; Eric Donaldson [États-Unis] ; Anjeanette Roberts [États-Unis] ; Leatrice Vogel [États-Unis] ; Becky Woodruff [États-Unis] ; Diana Scorpio [États-Unis] ; Kanta Subbarao [États-Unis] ; Ralph S. Baric [États-Unis] | Molecular Determinants of Severe Acute Respiratory Syndrome Coronavirus Pathogenesis and Virulence in Young and Aged Mouse Models of Human Disease |
| 001F77 (2012) |
Jasper F. W. Chan [Hong Kong] ; Kenneth S. M. Li [Hong Kong] ; Kelvin K. W. To [Hong Kong] ; Vincentc. C. Cheng [Hong Kong] ; HONGLIN CHEN [Hong Kong] ; Kwok-Yung Yuen [Hong Kong] | Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic? |
| 001F79 (2012) |
Carly Page [États-Unis] ; Lindsay Goicochea [États-Unis] ; Krystal Matthews [États-Unis] ; YONG ZHANG [États-Unis] ; Peter Klover [États-Unis] ; Michael J. Holtzman [États-Unis] ; Lothar Hennighausen [États-Unis] ; Matthew Frieman [États-Unis] | Induction of Alternatively Activated Macrophages Enhances Pathogenesis during Severe Acute Respiratory Syndrome Coronavirus Infection |
| 001F80 (2012) |
Mridula Rani [États-Unis] ; Meagan Bolles [États-Unis] ; Eric F. Donaldson [États-Unis] ; Thomas Van Blarcom [États-Unis] ; Ralph Baric [États-Unis] ; Brent Iverson [États-Unis] ; George Georgiou [États-Unis] | Increased Antibody Affinity Confers Broad In Vitro Protection against Escape Mutants of Severe Acute Respiratory Syndrome Coronavirus |
| 001F85 (2012) |
Thi Thanh Hanh Nguyen [Corée du Sud, États-Unis] ; Hye-Jin Woo [Corée du Sud, États-Unis] ; Hee-Kyoung Kang [Corée du Sud, États-Unis] ; VAN DAO NGUYEN [Viêt Nam] ; Young-Min Kim [Corée du Sud] ; Do-Won Kim [Corée du Sud] ; Sul-Ah Ahn [Corée du Sud] ; YONGMEI XIA [République populaire de Chine] ; Doman Kim [États-Unis] | Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris |
| 001F86 (2012) |
Ann Demogines [États-Unis] ; Michael Farzan [États-Unis] ; Sara L. Sawyer [États-Unis] | Evidence for ACE2-Utilizing Coronaviruses (CoVs) Related to Severe Acute Respiratory Syndrome CoV in Bats |
| 001F91 (2012) |
Tanel Mahlakoiv [Allemagne] ; Daniel Ritz [Allemagne] ; Markus Mordstein [Allemagne] ; Marta L. Dediego [Espagne] ; Luis Enjuanes [Espagne] ; Marcel A. Müller [Allemagne] ; Christian Drosten [Allemagne] ; Peter Staeheli [Allemagne] | Combined action of type I and type III interferon restricts initial replication of severe acute respiratory syndrome coronavirus in the lung but fails to inhibit systemic virus spread |
| 001F94 (2012) |
PENG ZHOU [République populaire de Chine] ; HONGXIA LI [République populaire de Chine] ; HANZHONG WANG [République populaire de Chine] ; Wang Lin-Fa [Australie] ; ZHENGLI SHI [République populaire de Chine] | Bat severe acute respiratory syndrome-like coronavirus ORF3b homologues display different interferon antagonist activities |
| 002011 (2011) |
Thi Thanh Hanh Nguyen [Corée du Sud] ; Hwa-Ja Ryu ; Se-Hoon Lee ; Soonwook Hwang ; Vincent Breton ; Joon Haeng Rhee ; Doman Kim | Virtual screening identification of novel severe acute respiratory syndrome 3C-like protease inhibitors and in vitro confirmation. |
| 002300 (2011) |
Andreas V. Hadjinicolaou [Chypre (pays)] ; Gabriella A. Farcas [Canada] ; Victoria L. Demetriou [Chypre (pays)] ; Tony Mazzulli [Canada] ; Susan M. Poutanen [Canada] ; Barbara M. Willey [Canada] ; Donald E. Low [Canada] ; Jagdish Butany [Canada] ; Sylvia L. Asa [Canada] ; Kevin C. Kain [Canada] ; Leondios G. Kostrikis [Chypre (pays)] | Development of a molecular-beacon-based multi-allelic real-time RT-PCR assay for the detection of human coronavirus causing severe acute respiratory syndrome (SARS-CoV): a general methodology for detecting rapidly mutating viruses |
| 002355 (2011) |
Thomas Kuri [Allemagne] ; Klara K. Eriksson [Suisse] ; Akos Putics [Allemagne] ; Roland Züst [Suisse] ; Eric J. Snijder [Pays-Bas] ; Andrew D. Davidson [Royaume-Uni] ; Stuart G. Siddell [Royaume-Uni] ; Volker Thiel [Suisse] ; John Ziebuhr [Allemagne] ; Friedemann Weber [Allemagne] | The ADP-ribose-1"-monophosphatase domains of severe acute respiratory syndrome coronavirus and human coronavirus 229E mediate resistance to antiviral interferon responses |
| 002356 (2011) |
Timothy Sheahan [États-Unis] ; Alan Whitmore [États-Unis] ; Kristin Long [États-Unis] ; Martin Ferris [États-Unis] ; Barry Rockx [États-Unis] ; William Funkhouser [États-Unis] ; Eric Donaldson [États-Unis] ; Lisa Gralinski [États-Unis] ; Martha Collier [États-Unis] ; Mark Heise [États-Unis] ; Nancy Davis [États-Unis] ; Robert Johnston [États-Unis] ; Ralph S. Baric [États-Unis] | Successful Vaccination Strategies That Protect Aged Mice from Lethal Challenge from Influenza Virus and Heterologous Severe Acute Respiratory Syndrome Coronavirus |
| 002358 (2011) |
Yohichi Kumaki [États-Unis] ; Jane Ennis [Canada] ; Ramtin Rahbar [Canada] ; Jeffrey D. Turner [Canada] ; Miles K. Wandersee [États-Unis] ; Aaron J. Smith [États-Unis] ; Kevin W. Bailey [États-Unis] ; Zachary G. Vest [États-Unis] ; Jason R. Madsen [États-Unis] ; Joseph K.-K. L [États-Unis] ; Dale L. Barnard [États-Unis] | Single-dose intranasal administration with mDEF201 (adenovirus vectored mouse interferon-alpha) confers protection from mortality in a lethal SARS-CoV BALB/c mouse model |
| 002359 (2011) |
Shih-Wein Li [Taïwan] ; Chien-Chen Lai [Taïwan] ; Jia-Fong Ping [Taïwan] ; Fuu-Jen Tsai [Taïwan] ; LEI WAN [Taïwan] ; Ying-Ju Lin [Taïwan] ; Szu-Hao Kung [Taïwan] ; Cheng-Wen Lin [Taïwan] | Severe acute respiratory syndrome coronavirus papain-like protease suppressed alpha interferon-induced responses through downregulation of extracellular signal-regulated kinase 1-mediated signalling pathways |
| 002360 (2011) |
Meriadeg Ar Gouilh [France, Thaïlande] ; Sebastien J. Puechmaille [Irlande (pays)] ; Jean-Paul Gonzalez [Gabon] ; Emma Teeling [Irlande (pays)] ; Pattamaporn Kittayapong [Thaïlande] ; Jean-Claude Manuguerra [France] | SARS-Coronavirus ancestor's foot-prints in South-East Asian bat colonies and the refuge theory |
| 002361 (2011) |
Choong-Tat Keng [Singapour] ; Sara Akerström [Suède] ; Cynthia Sau-Wai Leung [Hong Kong] ; Leo L. M. Poon [Hong Kong] ; J. S. Malik Peiris [Hong Kong] ; Ali Mirazimi [Suède] ; Yee-Joo Tan [Singapour] | SARS coronavirus 8b reduces viral replication by down-regulating E via an ubiquitin-independent proteasome pathway |
| 002366 (2011) |
LIFENG LIU [République populaire de Chine] ; JING XIE [République populaire de Chine] ; JIANPIN SUN [République populaire de Chine] ; YANG HAN [République populaire de Chine] ; CHAO ZHANG [République populaire de Chine] ; HONGWEI FAN [République populaire de Chine] ; ZHENGYIN LIU [République populaire de Chine] ; ZHIFENG QIU [République populaire de Chine] ; YUXIAN HE [République populaire de Chine] ; TAISHENG LI [République populaire de Chine] | Longitudinal profiles of immunoglobulin G antibodies against severe acute respiratory syndrome coronavirus components and neutralizing activities in recovered patients |
| 002372 (2011) |
Jennifer R. Cohen [États-Unis] ; Lisa D. Lin [États-Unis] ; Carolyn E. Machamer [États-Unis] | Identification of a Golgi Complex-Targeting Signal in the Cytoplasmic Tail of the Severe Acute Respiratory Syndrome Coronavirus Envelope Protein |
| 002374 (2011) |
Tohru Miyoshi-Akiyama [Japon] ; Isao Ishida [Japon] ; Masaya Fukushi [Japon] ; Keina Yamaguchi [Japon] ; Yusuke Matsuoka [Japon] ; Takashi Ishihara [Japon] ; Masayoshi Tsukahara [Japon] ; Seisuke Hatakeyama [Japon] ; Norikazu Itoh [Japon] ; Aki Morisawa [Japon] ; Yoshiyuki Yoshinaka [Japon] ; Naoki Yamamoto [Japon] ; ZHANG LIANFENG [République populaire de Chine] ; QIN CHUAN [République populaire de Chine] ; Teruo Kirikae [Japon] ; Takehiko Sasazuki [Japon] | Fully Human Monoclonal Antibody Directed to Proteolytic Cleavage Site in Severe Acute Respiratory Syndrome (SARS) Coronavirus S Protein Neutralizes the Virus in a Rhesus Macaque SARS Model |
| 002375 (2011) |
Ilona Glowacka [Allemagne] ; Stephanie Bertram [Allemagne] ; Marcel A. Müller [Allemagne] ; Paul Allen [Royaume-Uni] ; Elizabeth Soilleux [Royaume-Uni] ; Susanne Pfefferle [Allemagne] ; Imke Steffen [Allemagne] ; Theodros Solomon Tsegaye [Allemagne] ; YUXIAN HE [République populaire de Chine] ; Kerstin Gnirss [Allemagne] ; Daniela Niemeyer [Allemagne] ; Heike Schneider [Allemagne] ; Christian Drosten [Allemagne] ; Stefan Pöhlmann [Allemagne] | Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response |
| 002376 (2011) |
LI LIU [Hong Kong] ; QIANG WEI [République populaire de Chine] ; Xavier Alvarez [États-Unis] ; HAIBO WANG [Hong Kong] ; YANHUA DU [Hong Kong] ; HUA ZHU [République populaire de Chine] ; HONG JIANG [République populaire de Chine] ; JINGYING ZHOU [Hong Kong] ; Pokman Lam [Hong Kong] ; LINQI ZHANG [République populaire de Chine] ; Andrew Lackner [États-Unis] ; CHUAN QIN [République populaire de Chine] ; ZHIWEI CHEN [Hong Kong] | Epithelial Cells Lining Salivary Gland Ducts Are Early Target Cells of Severe Acute Respiratory Syndrome Coronavirus Infection in the Upper Respiratory Tracts of Rhesus Macaques |
| 002377 (2011) |
Hsueh-Ling Janice Oh [Singapour] ; Adeline Chia [Singapour] ; CYNTHIA XIN LEI CHANG [Singapour] ; HOE NAM LEONG [Singapour] ; KHOON LIN LING [Singapour] ; Gijsbert M. Grotenbreg [Singapour] ; Adam J. Gehring [Singapour] ; YEE JOO TAN [Singapour] ; Antonio Bertoletti [Singapour] | Engineering T Cells Specific for a Dominant Severe Acute Respiratory Syndrome Coronavirus CD8 T Cell Epitope |
| 002380 (2011) |
Saskia L. Smits [Pays-Bas] ; Judith M. A. Van Den Brand [Pays-Bas] ; Anna De Lang [Pays-Bas] ; Lonneke M. E. Leijten [Pays-Bas] ; Wilfred F. Van Ijcken [Pays-Bas] ; Geert Van Amerongen [Pays-Bas] ; Albert D. M. E. Osterhaus [Pays-Bas] ; Arno C. Andeweg [Pays-Bas] ; Bart L. Haagmans [Pays-Bas] | Distinct Severe Acute Respiratory Syndrome Coronavirus-Induced Acute Lung Injury Pathways in Two Different Nonhuman Primate Species |
| 002384 (2011) |
Stephanie Bertram [Allemagne] ; Ilona Glowacka [Allemagne] ; Marcel A. Müller [Allemagne] ; Hayley Lavender [Royaume-Uni] ; Kerstin Gnirss [Allemagne] ; Inga Nehlmeier [Allemagne] ; Daniela Niemeyer [Allemagne] ; YUXIAN HE [République populaire de Chine] ; Graham Simmons [États-Unis] ; Christian Drosten [Allemagne] ; Elizabeth J. Soilleux [Royaume-Uni] ; Olaf Jahn [Allemagne] ; Imke Steffen [Allemagne, États-Unis] ; Stefan Pöhlmann [Allemagne] | Cleavage and Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by Human Airway Trypsin-Like Protease |
| 002385 (2011) |
Ye V. Liu [États-Unis] ; Michael J. Massare [États-Unis] ; Dale L. Barnard [États-Unis] ; Thomas Kort [États-Unis] ; Margret Nathan [États-Unis] ; LEI WANG [États-Unis] ; Gale Smith [États-Unis] | Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV |
| 002387 (2011) |
Martial Jaume [Hong Kong] ; Ming S. Yip [Hong Kong] ; Chung Y. Cheung [Hong Kong] ; Hiu L. Leung [Hong Kong] ; Ping H. Li [Hong Kong] ; Francois Kien [Hong Kong] ; Isabelle Dutry [Hong Kong] ; Benoit Callendret [France] ; Nicolas Escriou [France] ; Ralf Altmeyer [Hong Kong] ; Beatrice Nal [Hong Kong] ; Marc Daëron [France] ; Roberto Bruzzone [Hong Kong, France] ; J. S. Malik Peiris [Hong Kong] | Anti-Severe Acute Respiratory Syndrome Coronavirus Spike Antibodies Trigger Infection of Human Immune Cells via a pH- and Cysteine Protease-Independent FcγR Pathway |
| 002390 (2011) |
Ana Shulla [États-Unis] ; Taylor Heald-Sargent [États-Unis] ; Gitanjali Subramanya [États-Unis] ; JINCUN ZHAO [États-Unis] ; Stanley Perlman [États-Unis] ; Tom Gallagher [États-Unis] | A Transmembrane Serine Protease Is Linked to the Severe Acute Respiratory Syndrome Coronavirus Receptor and Activates Virus Entry |
| 002391 (2011) |
Meagan Bolles [États-Unis] ; Damon Deming [États-Unis] ; Kristin Long [États-Unis] ; Sudhakar Agnihothram [États-Unis] ; Alan Whitmore [États-Unis] ; Martin Ferris [États-Unis] ; William Funkhouser [États-Unis] ; Lisa Gralinski [États-Unis] ; Allison Totura [États-Unis] ; Mark Heise [États-Unis] ; Ralph S. Baric [États-Unis] | A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response upon Challenge |
| 002620 (2010) |
Johannes Chi-Yun Ching [Hong Kong] ; Kelvin Yuen Kwong Chan [Hong Kong] ; Eric Hing Leung Lee [Hong Kong] ; Mei-Shu Xu [Hong Kong] ; Campbell Kam Po Ting [Hong Kong] ; Thomas M. K. So [Hong Kong] ; Pak C. Sham [Hong Kong] ; Gabriel M. Leung [Hong Kong] ; Joseph S. M. Peiris [Hong Kong] ; Ui-Soon Khoo [Hong Kong] | Significance of the Myxovirus Resistance A (MxA) Gene — 123C>A Single-Nucleotide Polymorphism in Suppressed Interferon β Induction of Severe Acute Respiratory Syndrome Coronavirus Infection |
| 002653 (2010) |
Barry Rockx [États-Unis] ; Eric Donaldson ; Matthew Frieman ; Timothy Sheahan ; Davide Corti [Suisse] ; Antonio Lanzavecchia [Suisse] ; Ralph S. Baric | Escape from Human Monoclonal Antibody Neutralization Affects In Vitro and In Vivo Fitness of Severe Acute Respiratory Syndrome Coronavirus |
| 002909 (2010) |
I-Yin Chen [Taïwan] ; Shin C. Chang [Taïwan] ; Hung-Yi Wu [Taïwan] ; Ting-Chun Yu [Taïwan] ; Wen-Chin Wei [Taïwan] ; SHIMING LIN [Taïwan] ; Chung-Liang Chien [Taïwan] ; Ming-Fu Chang [Taïwan] | Upregulation of the Chemokine (C-C Motif) Ligand 2 via a Severe Acute Respiratory Syndrome Coronavirus Spike-ACE2 Signaling Pathway |
